Medicine and Dentistry
Patient
100%
Prevalence
20%
Myelodysplastic Syndrome
20%
Hematology
20%
Protein Tyrosine Kinase
20%
Chronic Myelogenous Leukemia
20%
Budd-Chiari Syndrome
20%
Mycosis
20%
Complication
20%
Prognosis
20%
Liver Transplantation
20%
Janus Kinase 2
20%
Chemotherapy
20%
Cytokine
20%
Hematopoietic Stem Cell Transplantation
20%
Chromosome 5
20%
Myeloproliferative Disorder
12%
Hazard Ratio
10%
Protein P53
10%
Mutant
10%
Follow up
9%
Therapeutic Procedure
7%
Incidence
7%
Gene
5%
Single Nucleotide Polymorphism
5%
Retransplantation
5%
Liver
5%
International Prognostic Scoring System
5%
Myeloid Malignancy
5%
Protein Expression
5%
Overall Survival
5%
Age
5%
Adjustment
5%
Azacitidine
5%
Biochemistry, Genetics and Molecular Biology
Gene
58%
Next Generation Sequencing
40%
Protein
27%
Epigenetics
26%
Spliceosome
20%
Uniparental Disomy
20%
Exon
20%
Tyrosine Kinase
20%
Dysplasia
20%
Single-Nucleotide Polymorphism
15%
Karyotyping
15%
Cytogenetics
13%
Stop Codon
11%
Tyrosine Kinase Inhibitor
10%
SF3B1
8%
Dideoxynucleotide Sequencing
6%
Tiling Array
6%
Transcription Termination
6%
ChIP-on-chip
6%
Methylation
6%
Ectopic Expression
5%
Lymphocyte Transformation
5%
Amino Acids
5%
Spectrum
5%
Frameshift Mutation
5%
Reduction (Chemistry)
5%
Chromosomal Aberration
5%
Wild Type
5%
Immunology and Microbiology
Cytotoxic T-Cell
24%
T Cell Proliferation
20%
T Cell Activation
20%
Leukemia Cell
20%
Liver
10%
Bone Marrow
10%
Abscess
10%
T-Helper Cell
9%
Graft-Versus-Host Disease
8%
Immunosuppression
8%
Viral Life Cycle
8%
Immunosuppressive Therapy
7%
T Cell Subset
5%
Immunosuppressive Drug
5%
Dendritic Cell
5%
Granulocyte
5%
Monocyte
5%
CLEC7A
5%
Innate Immune System
5%
TLR3
5%
TLR2
5%
TLR6
5%
Adaptive Immune System
5%
